United States · FDA National Drug Code directory
TUKYSA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51144-002_892c322b-be43-4180-89f7-4e3619a8b58f
- Product NDC
- 51144-002
- Form
- TABLET
- Composition / generic term
- tucatinib
- Labeler
- SEAGEN INC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200417
- Source listing expiry
- 20261231
Source-listed ingredients
- TUCATINIB — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (51144-002-12) · 51144-002-12
- 60 TABLET in 1 BOTTLE (51144-002-60) · 51144-002-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →